Effect  ||| S:0 E:7 ||| NN
of  ||| S:7 E:10 ||| IN
feed  ||| S:10 E:15 ||| NN
restriction  ||| S:15 E:27 ||| NN
on  ||| S:27 E:30 ||| IN
plasma  ||| S:30 E:37 ||| FW
dantrolene  ||| S:37 E:48 ||| FW
concentrations  ||| S:48 E:63 ||| FW
in  ||| S:63 E:66 ||| FW
horses  ||| S:66 E:73 ||| FW
Dantrolene  ||| S:73 E:84 ||| FW
sodium  ||| S:84 E:91 ||| FW
is  ||| S:91 E:94 ||| VBZ
used  ||| S:94 E:99 ||| VBN
to  ||| S:99 E:102 ||| TO
prevent  ||| S:102 E:110 ||| VB
exertional  ||| S:110 E:121 ||| JJ
rhabdomyolysis  ||| S:121 E:136 ||| NN
in  ||| S:136 E:139 ||| IN
predisposed  ||| S:139 E:151 ||| JJ
horses ||| S:151 E:157 ||| NNS
.  ||| S:157 E:159 ||| .
Food  ||| S:159 E:164 ||| NN
intake  ||| S:164 E:171 ||| NN
might  ||| S:171 E:177 ||| MD
negatively  ||| S:177 E:188 ||| RB
impact  ||| S:188 E:195 ||| VB
dantrolene  ||| S:195 E:206 ||| JJ
bioavailability  ||| S:206 E:222 ||| NN
in  ||| S:222 E:225 ||| IN
horses ||| S:225 E:231 ||| NNS
;  ||| S:231 E:233 ||| :
however ||| S:233 E:240 ||| RB
,  ||| S:240 E:242 ||| ,
prolonged  ||| S:242 E:252 ||| JJ
feed  ||| S:252 E:257 ||| NN
restriction  ||| S:257 E:269 ||| NN
might  ||| S:269 E:275 ||| MD
be  ||| S:275 E:278 ||| VB
detrimental  ||| S:278 E:290 ||| VBN
to  ||| S:290 E:293 ||| TO
performance ||| S:293 E:304 ||| NN
.  ||| S:304 E:306 ||| .
To  ||| S:306 E:309 ||| TO
determine  ||| S:309 E:319 ||| VB
a  ||| S:319 E:321 ||| DT
minimum  ||| S:321 E:329 ||| JJ
duration  ||| S:329 E:338 ||| NN
of  ||| S:338 E:341 ||| IN
feed  ||| S:341 E:346 ||| NN
restriction  ||| S:346 E:358 ||| NN
that  ||| S:358 E:363 ||| WDT
would  ||| S:363 E:369 ||| MD
optimise  ||| S:369 E:378 ||| VB
plasma  ||| S:378 E:385 ||| JJ
dantrolene  ||| S:385 E:396 ||| JJ
concentrations  ||| S:396 E:411 ||| NNS
in  ||| S:411 E:414 ||| IN
horses  ||| S:414 E:421 ||| NNS
after  ||| S:421 E:427 ||| IN
nasogastric  ||| S:427 E:439 ||| JJ
administration ||| S:439 E:453 ||| NN
.  ||| S:453 E:455 ||| .
It  ||| S:455 E:458 ||| PRP
was  ||| S:458 E:462 ||| VBD
hypothesised  ||| S:462 E:475 ||| VBN
that  ||| S:475 E:480 ||| IN
feed  ||| S:480 E:485 ||| NN
restriction  ||| S:485 E:497 ||| NN
for  ||| S:497 E:501 ||| IN
4 ||| S:501 E:502 ||| CD
,  ||| S:502 E:504 ||| ,
8  ||| S:504 E:506 ||| CD
or  ||| S:506 E:509 ||| CC
12  ||| S:509 E:512 ||| CD
h  ||| S:512 E:514 ||| NN
before  ||| S:514 E:521 ||| IN
dantrolene  ||| S:521 E:532 ||| JJ
administration  ||| S:532 E:547 ||| NN
would  ||| S:547 E:553 ||| MD
result  ||| S:553 E:560 ||| VB
in  ||| S:560 E:563 ||| IN
higher  ||| S:563 E:570 ||| JJR
plasma  ||| S:570 E:577 ||| JJ
dantrolene  ||| S:577 E:588 ||| JJ
concentrations  ||| S:588 E:603 ||| NNS
than  ||| S:603 E:608 ||| IN
achieved  ||| S:608 E:617 ||| VBN
with  ||| S:617 E:622 ||| IN
no  ||| S:622 E:625 ||| DT
feed  ||| S:625 E:630 ||| NN
restriction  ||| S:630 E:642 ||| NN
before  ||| S:642 E:649 ||| IN
treatment ||| S:649 E:658 ||| NN
.  ||| S:658 E:660 ||| .
Five  ||| S:660 E:665 ||| CD
healthy  ||| S:665 E:673 ||| JJ
horses  ||| S:673 E:680 ||| NNS
were  ||| S:680 E:685 ||| VBD
randomly  ||| S:685 E:694 ||| RB
rotated  ||| S:694 E:702 ||| VBN
through  ||| S:702 E:710 ||| IN
4  ||| S:710 E:712 ||| CD
feed  ||| S:712 E:717 ||| NN
restriction  ||| S:717 E:729 ||| NN
periods  ||| S:729 E:737 ||| NNS
of  ||| S:737 E:740 ||| IN
0 ||| S:740 E:741 ||| CD
,  ||| S:741 E:743 ||| ,
4 ||| S:743 E:744 ||| CD
,  ||| S:744 E:746 ||| ,
8  ||| S:746 E:748 ||| CD
and  ||| S:748 E:752 ||| CC
12  ||| S:752 E:755 ||| CD
h  ||| S:755 E:757 ||| NNS
duration  ||| S:757 E:766 ||| VBP
prior  ||| S:766 E:772 ||| RB
to  ||| S:772 E:775 ||| TO
nasogastric  ||| S:775 E:787 ||| VB
administration  ||| S:787 E:802 ||| NN
of  ||| S:802 E:805 ||| IN
dantrolene  ||| S:805 E:816 ||| JJ
sodium  ||| S:816 E:823 ||| NNS
( ||| S:823 E:824 ||| -LRB-
6  ||| S:824 E:826 ||| CD
mg ||| S:826 E:828 ||| CD
/ ||| S:828 E:829 ||| CD
kg  ||| S:829 E:832 ||| CD
bwt ||| S:832 E:835 ||| CD
) ||| S:835 E:836 ||| -RRB-
.  ||| S:836 E:838 ||| .
Plasma  ||| S:838 E:845 ||| JJ
dantrolene  ||| S:845 E:856 ||| JJ
concentration  ||| S:856 E:870 ||| NN
was  ||| S:870 E:874 ||| VBD
measured  ||| S:874 E:883 ||| VBN
by  ||| S:883 E:886 ||| IN
spectrofluorometry  ||| S:886 E:905 ||| NN
at  ||| S:905 E:908 ||| IN
60 ||| S:908 E:910 ||| CD
,  ||| S:910 E:912 ||| ,
90 ||| S:912 E:914 ||| CD
,  ||| S:914 E:916 ||| ,
120 ||| S:916 E:919 ||| CD
,  ||| S:919 E:921 ||| ,
150 ||| S:921 E:924 ||| CD
,  ||| S:924 E:926 ||| ,
180  ||| S:926 E:930 ||| CD
and  ||| S:930 E:934 ||| CC
210  ||| S:934 E:938 ||| CD
min  ||| S:938 E:942 ||| NN
after  ||| S:942 E:948 ||| IN
administration ||| S:948 E:962 ||| NN
.  ||| S:962 E:964 ||| .
Data  ||| S:964 E:969 ||| NNP
were  ||| S:969 E:974 ||| VBD
analysed  ||| S:974 E:983 ||| VBN
via  ||| S:983 E:987 ||| IN
repeated  ||| S:987 E:996 ||| JJ
measures  ||| S:996 E:1005 ||| NNS
ANOVA ||| S:1005 E:1010 ||| NNP
.  ||| S:1010 E:1012 ||| .
Peak  ||| S:1012 E:1017 ||| JJ
plasma  ||| S:1017 E:1024 ||| JJ
dantrolene  ||| S:1024 E:1035 ||| JJ
concentration  ||| S:1035 E:1049 ||| NN
was  ||| S:1049 E:1053 ||| VBD
highest  ||| S:1053 E:1061 ||| JJS
when  ||| S:1061 E:1066 ||| WRB
horses  ||| S:1066 E:1073 ||| NNS
had  ||| S:1073 E:1077 ||| VBD
0  ||| S:1077 E:1079 ||| CD
and  ||| S:1079 E:1083 ||| CC
4  ||| S:1083 E:1085 ||| CD
h  ||| S:1085 E:1087 ||| NN
of  ||| S:1087 E:1090 ||| IN
feed  ||| S:1090 E:1095 ||| NN
restriction  ||| S:1095 E:1107 ||| NN
( ||| S:1107 E:1108 ||| -LRB-
0.65  ||| S:1108 E:1113 ||| CD
±  ||| S:1113 E:1115 ||| CD
0.10  ||| S:1115 E:1120 ||| CD
µg ||| S:1120 E:1122 ||| CD
/ ||| S:1122 E:1123 ||| CD
ml  ||| S:1123 E:1126 ||| NN
at  ||| S:1126 E:1129 ||| IN
120  ||| S:1129 E:1133 ||| CD
min ||| S:1133 E:1136 ||| NNS
;  ||| S:1136 E:1138 ||| :
0.66  ||| S:1138 E:1143 ||| CD
±  ||| S:1143 E:1145 ||| CD
0.17  ||| S:1145 E:1150 ||| CD
at  ||| S:1150 E:1153 ||| IN
180  ||| S:1153 E:1157 ||| CD
min ||| S:1157 E:1160 ||| NN
,  ||| S:1160 E:1162 ||| ,
respectively ||| S:1162 E:1174 ||| RB
)  ||| S:1174 E:1176 ||| -RRB-
and  ||| S:1176 E:1180 ||| CC
was  ||| S:1180 E:1184 ||| VBD
lower  ||| S:1184 E:1190 ||| JJR
when  ||| S:1190 E:1195 ||| WRB
horses  ||| S:1195 E:1202 ||| NNS
were  ||| S:1202 E:1207 ||| VBD
restricted  ||| S:1207 E:1218 ||| VBN
from  ||| S:1218 E:1223 ||| IN
feed  ||| S:1223 E:1228 ||| NN
for  ||| S:1228 E:1232 ||| IN
8  ||| S:1232 E:1234 ||| CD
h  ||| S:1234 E:1236 ||| NNS
( ||| S:1236 E:1237 ||| -LRB-
0.45  ||| S:1237 E:1242 ||| CD
±  ||| S:1242 E:1244 ||| CD
0.15  ||| S:1244 E:1249 ||| CD
at  ||| S:1249 E:1252 ||| IN
150  ||| S:1252 E:1256 ||| CD
min ||| S:1256 E:1259 ||| CD
)  ||| S:1259 E:1261 ||| -RRB-
and  ||| S:1261 E:1265 ||| CC
12  ||| S:1265 E:1268 ||| CD
h  ||| S:1268 E:1270 ||| NNS
( ||| S:1270 E:1271 ||| -LRB-
0.21  ||| S:1271 E:1276 ||| CD
±  ||| S:1276 E:1278 ||| CD
0.09  ||| S:1278 E:1283 ||| CD
at  ||| S:1283 E:1286 ||| IN
180  ||| S:1286 E:1290 ||| CD
min ||| S:1290 E:1293 ||| CD
) ||| S:1293 E:1294 ||| -RRB-
.  ||| S:1294 E:1296 ||| .
Mean  ||| S:1296 E:1301 ||| VB
plasma  ||| S:1301 E:1308 ||| JJ
dantrolene  ||| S:1308 E:1319 ||| JJ
concentration  ||| S:1319 E:1333 ||| NN
did  ||| S:1333 E:1337 ||| VBD
not  ||| S:1337 E:1341 ||| RB
differ  ||| S:1341 E:1348 ||| VB
between  ||| S:1348 E:1356 ||| IN
0  ||| S:1356 E:1358 ||| CD
and  ||| S:1358 E:1362 ||| CC
4  ||| S:1362 E:1364 ||| CD
h  ||| S:1364 E:1366 ||| JJ
feed  ||| S:1366 E:1371 ||| NN
restriction  ||| S:1371 E:1383 ||| NN
at  ||| S:1383 E:1386 ||| IN
any  ||| S:1386 E:1390 ||| DT
sample  ||| S:1390 E:1397 ||| NN
time ||| S:1397 E:1401 ||| NN
,  ||| S:1401 E:1403 ||| ,
but  ||| S:1403 E:1407 ||| CC
feed  ||| S:1407 E:1412 ||| NN
restriction  ||| S:1412 E:1424 ||| NN
for  ||| S:1424 E:1428 ||| IN
8  ||| S:1428 E:1430 ||| CD
h  ||| S:1430 E:1432 ||| NNS
resulted  ||| S:1432 E:1441 ||| VBD
in  ||| S:1441 E:1444 ||| IN
significantly  ||| S:1444 E:1458 ||| RB
lower  ||| S:1458 E:1464 ||| RBR
plasma  ||| S:1464 E:1471 ||| JJ
dantrolene  ||| S:1471 E:1482 ||| JJ
concentration  ||| S:1482 E:1496 ||| NN
at  ||| S:1496 E:1499 ||| IN
60  ||| S:1499 E:1502 ||| CD
and  ||| S:1502 E:1506 ||| CC
180  ||| S:1506 E:1510 ||| CD
min  ||| S:1510 E:1514 ||| NN
after  ||| S:1514 E:1520 ||| IN
treatment  ||| S:1520 E:1530 ||| NN
than  ||| S:1530 E:1535 ||| IN
when  ||| S:1535 E:1540 ||| WRB
horses  ||| S:1540 E:1547 ||| NNS
were  ||| S:1547 E:1552 ||| VBD
restricted  ||| S:1552 E:1563 ||| VBN
0  ||| S:1563 E:1565 ||| CD
and  ||| S:1565 E:1569 ||| CC
4  ||| S:1569 E:1571 ||| CD
h ||| S:1571 E:1572 ||| NN
,  ||| S:1572 E:1574 ||| ,
respectively ||| S:1574 E:1586 ||| RB
.  ||| S:1586 E:1588 ||| .
Plasma  ||| S:1588 E:1595 ||| JJ
dantrolene  ||| S:1595 E:1606 ||| JJ
concentration  ||| S:1606 E:1620 ||| NN
was  ||| S:1620 E:1624 ||| VBD
significantly  ||| S:1624 E:1638 ||| RB
lower  ||| S:1638 E:1644 ||| JJR
at  ||| S:1644 E:1647 ||| IN
all  ||| S:1647 E:1651 ||| DT
sample  ||| S:1651 E:1658 ||| NN
times  ||| S:1658 E:1664 ||| NNS
when  ||| S:1664 E:1669 ||| WRB
horses  ||| S:1669 E:1676 ||| NNS
were  ||| S:1676 E:1681 ||| VBD
restricted  ||| S:1681 E:1692 ||| VBN
from  ||| S:1692 E:1697 ||| IN
feed  ||| S:1697 E:1702 ||| CD
12  ||| S:1702 E:1705 ||| CD
h  ||| S:1705 E:1707 ||| NNS
compared  ||| S:1707 E:1716 ||| VBN
to  ||| S:1716 E:1719 ||| TO
0  ||| S:1719 E:1721 ||| CD
or  ||| S:1721 E:1724 ||| CC
4  ||| S:1724 E:1726 ||| CD
h ||| S:1726 E:1727 ||| NNS
.  ||| S:1727 E:1729 ||| .
Absorption  ||| S:1729 E:1740 ||| NNP
of  ||| S:1740 E:1743 ||| IN
nasogastrically  ||| S:1743 E:1759 ||| JJ
administered  ||| S:1759 E:1772 ||| JJ
dantrolene  ||| S:1772 E:1783 ||| NN
is  ||| S:1783 E:1786 ||| VBZ
inhibited  ||| S:1786 E:1796 ||| VBN
by  ||| S:1796 E:1799 ||| IN
feed  ||| S:1799 E:1804 ||| NN
restriction  ||| S:1804 E:1816 ||| NN
before  ||| S:1816 E:1823 ||| IN
administration ||| S:1823 E:1837 ||| NN
.  ||| S:1837 E:1839 ||| .
To  ||| S:1839 E:1842 ||| TO
achieve  ||| S:1842 E:1850 ||| VB
optimal  ||| S:1850 E:1858 ||| JJ
plasma  ||| S:1858 E:1865 ||| JJ
dantrolene  ||| S:1865 E:1876 ||| JJ
concentrations ||| S:1876 E:1890 ||| NNS
,  ||| S:1890 E:1892 ||| ,
feed  ||| S:1892 E:1897 ||| NN
restriction  ||| S:1897 E:1909 ||| NN
before  ||| S:1909 E:1916 ||| IN
oral  ||| S:1916 E:1921 ||| JJ
administration  ||| S:1921 E:1936 ||| NN
should  ||| S:1936 E:1943 ||| MD
not  ||| S:1943 E:1947 ||| RB
exceed  ||| S:1947 E:1954 ||| VB
4  ||| S:1954 E:1956 ||| CD
h ||| S:1956 E:1957 ||| NNS
.  ||| S:1957 E:1959 ||| .
